Delta-Fly Pharma Inc.: Update for Development Status of the Combination Study of DFP-10917 with Venetoclax
Following to the previous information on Oct. 28th. in 2024, we are excited to share our latest development status.
We are pleased to announce that the data review committee (DMC) has approved the tolerability of the first three patients enrolled in the Phase I/II clinical trial of DFP-10917 in combination with Venetoclax (VEN) (NCT06382168) conducted at five US clinical sites for patients with acute myeloid leukemia (AML) who have failed/relapsed after standard VEN therapy (first-line therapy). Additionally, the bone marrow cell count in peripheral blood in all three cases was 0 (zero) within 4 (four) weeks of starting treatment, and complete remission (CR or CRi) was confirmed by subsequent bone marrow biopsy.
Three more patients will be added at the current dosage regimen, and after confirmation of the tolerability, the study will move to Phase II. Complete remission has been observed in patients who have failed/relapsed after existing VEN combination therapy (first-line therapy), so this is expected to be a new, highly effective second-line therapy for patients with AML.
As previously reported, the data cleaning processes for interim analysis are currently underway for Phase III comparative clinical trial (150 cases) of DFP-10917 monotherapy targeting patients with AML receiving third-line or later therapy. Once this is completed, the results will be submitted to the Independent Data Safety Monitoring Committee (DSMB) along with electrocardiogram and pharmacokinetic study results for their advice.
Please take notice of our own innovative approach for miserable cancer patients and contact us.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241209579716/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Watchmaker Genomics Launches TAPS+, Expanding Multimodal Capabilities in Oncology Ahead of AMP 20255.11.2025 12:00:00 CET | Press release
- TAPS+ enables simultaneous detection of methylation and genetic variants, unlocking new insights for precision oncology and translational research. - Preserves DNA integrity in challenging clinically relevant samples, including FFPE tissue and circulating tumor DNA (ctDNA). - Platform-agnostic chemistry enables seamless integration across sequencing systems. Watchmaker Genomics today announced the launch of TAPS+, a next-generation technology that unites genetic and epigenetic readouts from the same DNA molecule. By capturing multiple biological dimensions in a single assay, TAPS+ delivers a richer, more comprehensive view of tumor biology, with the power to advance applications in translational oncology, early cancer detection, therapy response monitoring, fragmentomics, and minimal residual disease assessment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251105264633/en/ Watchmaker Genomics launches TAPS+, a next-gener
Xiid Launches Elite Advisory Board, Enlists Rachel Higham to Help Drive Next Phase of Growth5.11.2025 12:00:00 CET | Press release
Newly established brain trust includes top global executives who have led technology, security and transformation initiatives across telecommunications, consulting and enterprise IT Xiid Corp., which is revolutionizing cyber defense with zero knowledge networking, today announced it has assembled a distinguished advisory board and added Rachel Higham to this circle of trusted advisors. Formerly Marks & Spencer’s chief digital and technology officer, Higham will serve as a special advisor and consultant, leading Xiid’s go-to-market strategy with hyperscalers, colocation companies and telecom services providers. “Rachel contributes valuable perspective and experience,” said Xiid CEO Steve Visconti. “Now the new Xiid Advisory Board – which already includes global industry leaders with deep roots at such companies as Alcatel, Capgemini, Deloitte, Microsoft and Vodafone – is even stronger.” Higham learned of Xiid’s unique approach during her time with Marks & Spencer. In addition to her exp
Outreach Bolsters its EMEA Presence and Enhances Customer Experience with New General Manager5.11.2025 11:00:00 CET | Press release
Former Box VP Paul Ditchfield joins revenue orchestration leader to accelerate growth, increase AI adoption, and drive revenue for enterprise companies Outreach, the AI Revenue Workflow Platform, is amplifying its EMEA presence by hiring Paul Ditchfield as its new General Manager of EMEA. This move strengthens Outreach’s already vast presence in EMEA with offices in London and Prague, and a data center in Ireland. Ditchfield will lead Outreach’s rapidly growing EMEA team, working closely with customers such as SAP, Siemens, and Omniplex, and expanding Outreach’s presence across EMEA. With twenty-five years of experience in enterprise sales, Ditchfield brings a proven track record of leading revenue teams at Box, ON24, Adobe, and Global Graphics Software. “The rapid rise of AI advancements in EMEA makes it an even more exciting time for the revenue orchestration space,” said Abhijit Mitra, Outreach CEO. “Paul’s leadership and deep understanding of the enterprise software market will be
Corona Cero Brings Golden Moments to the Mountains of Milano Cortina 20265.11.2025 10:30:00 CET | Press release
First-ever no-alcohol beer sponsor of Olympic Winter Games celebrates “For Every Golden Moment” platform with consumers globally As the 100-day countdown to the Olympic Winter Games continues, and in a year the global Corona brand is celebrating its 100th anniversary, Corona Cero is officially set to bring golden moments to the slopes of Milano Cortina 2026. As the first no-alcohol beer sponsor of the Winter Olympics, the brand is revving up its “For Every Golden Moment” global platform to invite consumers to celebrate every golden moment any time, any season. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251105994873/en/ Corona Cero's "For Every Golden Moment" Olympic Winter Games What began at the Olympic Games Paris 2024, Corona Cero’s Olympics partnership reinforces that beer and sports are better together by offering consumers more choices for any occasion. Corona Cero’s role reflects AB InBev and the International Oly
Nissan and Infobip Achieve 200% Increase in Engagement with AI-Driven WhatsApp Campaign5.11.2025 10:00:00 CET | Press release
AI-powered voice game sets new standard for digital marketing Nissan has redefined customer engagement by partnering with global cloud communications platform Infobip to pioneer a first-of-its-kind Agentic AI campaign. Nissan Kingdom of Saudi Arabia (KSA) leveraged Infobip’s newly launched Conversational AI Gamification, an AI-powered toolset that enables playful, immersive experiences across messaging channels. The marketing campaign utilized Infobip's Vocalize feature, an AI-powered voice game where users competed to win a brand-new Nissan Magnite. Participants used their voices to match an audio waveform to the outline of a car, directly within WhatsApp. This innovative approach transformed lead generation into an engaging competition, driving user participation and brand interaction. For Nissan KSA, the campaign enhanced brand awareness, increased engagement time, simplified lead acquisition, and stronger brand affinity. The innovative format also provided a cost-effective acquisit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom